Free tool
FAERS Monitor: Propranolol Hydrochloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 016419 or its brand name (Propranolol Hydrochloride, Propranolol Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
11,347
Serious
7,703
68% of reports
Hospitalization
3,174
Death reported
1,470
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use1,804
- drug ineffective1,264
- nausea919
- product use in unapproved indication877
- product use issue869
- headache797
- fatigue770
- toxicity to various agents694
- diarrhoea624
- drug intolerance596
- dyspnoea564
- dizziness549
- completed suicide521
- vomiting460
- pain439
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 99 |
| 2005 | 162 |
| 2006 | 127 |
| 2007 | 98 |
| 2008 | 79 |
| 2009 | 153 |
| 2010 | 174 |
| 2011 | 164 |
| 2012 | 203 |
| 2013 | 141 |
| 2014 | 145 |
| 2015 | 149 |
| 2016 | 226 |
| 2017 | 242 |
| 2018 | 371 |
| 2019 | 386 |
| 2020 | 575 |
| 2021 | 873 |
| 2022 | 1,299 |
| 2023 | 1,477 |
| 2024 | 1,873 |
| 2025 | 1,263 |
| 2026 | 1,068 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,812 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| completed suicideSignal | 521 | 11.7 | 10.7 | 5,053 |
| drug intoleranceSignal | 596 | 11.5 | 10.6 | 5,695 |
| product use issueSignal | 869 | 8.6 | 8.1 | 5,859 |
| toxicity to various agentsSignal | 694 | 7.7 | 7.1 | 4,025 |
| product use in unapproved indicationSignal | 877 | 6.6 | 6.2 | 4,178 |
| off label useSignal | 1,804 | 3.8 | 3.7 | 3,916 |
| headacheSignal | 797 | 2.4 | 2.2 | 640 |
| nauseaSignal | 919 | 2.2 | 2.0 | 588 |
| dizzinessSignal | 549 | 2.0 | 1.9 | 297 |
| dyspnoea | 564 | 1.8 | 1.7 | 224 |
| fatigue | 770 | 1.8 | 1.7 | 302 |
| vomiting | 460 | 1.8 | 1.7 | 171 |
| diarrhoea | 624 | 1.8 | 1.7 | 225 |
| drug ineffective | 1,264 | 1.8 | 1.7 | 458 |
| pain | 439 | 1.3 | 1.2 | 36 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.